Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer (PARTIQoL)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by Massachusetts General Hospital
Sponsor:
Collaborators:
University of Pennsylvania
National Cancer Institute (NCI)
Northwestern University
M.D. Anderson Cancer Center
ProCure Proton Therapy Center
Washington University School of Medicine
University of Washington
Memorial Sloan Kettering Cancer Center
Rutgers Cancer Institute of New Jersey
Provision Center for Proton Therapy
Information provided by (Responsible Party):
Jason Efstathiou, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01617161
First received: June 8, 2012
Last updated: November 22, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)